Screener
Pacira BioSciences, Inc. PCRX Business Segments — Adjusted research and development
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept pcrx:ResearchAndDevelopmentAdjusted.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Revenues | $177,376 | $168,923 |
| Less: | ||
| Adjusted cost of goods sold (1) | 34,770 | 32,590 |
| Adjusted research and development (1) | 25,362 | 23,101 |
| Adjusted selling and marketing (1) | 58,166 | 55,571 |
| Adjusted general and administrative (1) | 25,712 | 20,609 |
| Stock-based compensation (1) | 13,539 | 14,553 |
| Amortization of acquired intangible assets | 14,322 | 14,322 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s business segments — adjusted research and development?
- Pacira BioSciences, Inc. (PCRX) reported business segments — adjusted research and development of $25.36M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — adjusted research and development changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — adjusted research and development increased by 9.8% year-over-year, from $23.1M to $25.36M.
- What is the long-term trend for Pacira BioSciences, Inc.'s business segments — adjusted research and development?
- Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — adjusted research and development has grown at a 10.2% compound annual growth rate (CAGR), from $78.2M to $104.7M.
- What does business segments — adjusted research and development mean?
- Captures the adjusted expenses incurred by the segment for research and development activities, excluding non-recurring charges. This metric reflects the company's commitment to innovation and the long-term pipeline development within this specific business area.
Ask your AI about Pacira BioSciences, Inc.'s business segments — adjusted research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude